ORF37 - Late-Breaking Oral Abstract/Rapid-Fire II

Invited Chair(s)

• RP

  Robin Peeters, MD,PhD

  Internist
  Erasmus Universiteit
  Rotterdam, Netherlands

  Disclosure information not submitted.

Presentations:

• 3:30 PM - 4:15 PM CT

  Dual-dose Cosyntropin Stimulation Testing to Assess HPA-axis Safety and Identify Non-Study Corticosteroid Exposure in a Phase 3 Ulcerative Colitis Trial
  

  Rapid and Poster Presenter: Elena A. Christofides, MD (she/her/hers) – ENDOCRINOLOGY ASSOCIATES, INC

  Co-Author: Mark Ensign, BS – Cristcot
• 3:30 PM - 4:15 PM CT

  Transforming Anabolic Treatments for Osteoporosis: New Clinical Data Supports a Single EB613 Tablet [Oral PTH(1-34)] as the Final Candidate for a Phase 3 Study
  

  Oral Abstract Presenter: Helen Pentikis, PhD – Saje Consulting LLC

  Co-Author: Gregory Burshtein, PhD – Entera Bio Ltd

  Co-Author: Constantin Itin, PhD – Entera Bio Ltd.

  Co-Author: Hillel Galitzer, PhD – Entera Bio Ltd

  Co-Author: Michal Kushnir, n/a – Entera Bio Ltd

  Co-Author: Anke Hoppe, n/a – Entera Bio Ltd

  Co-Author: Chana Sternberg, n/a – Chana Sternberg Consultancy Ltd.

  Co-Author: Helen Pentikis, PhD – Saje Consulting LLC

  Co-Author: Miranda Toledano, Ms – Entera

  Co-Author: Felicia Cosman, MD – Columbia University College of Physicians and Surgeons

  Senior Author/Primary Investigator: Yoseph Caraco, MD – Hadassah Medical Center
• 3:30 PM - 4:15 PM CT

  Cabozantinib in Advanced Adrenocortical Carcinoma after standard therapy: final phase 2 trial results and the relevance of prior mitotane use
  

  Co-Author: Miriam Reuter, MD – University Hospital Würzburg

  Co-Author: Maria-Elisabeth Goebeler, MD – University Hospital Würzburg

  Co-Author: Chrisoula Tahtsidou, n/a – LMU University

  Co-Author: Carmina Fuss, MD – University Hospital Würzburg

  Co-Author: Otilia Kimpel, MD – Department of Endocrinology, University Hospital Wrzburg

  Co-Author: Cyrus Sayehli, MD, PhD – University Hospital Würzburg

  Co-Author: Horst-Dieter Hummel, MD – University Hospital Würzburg

  Co-Author: Laura-Sophie Landwehr, Dr. rer. nat. (she/her/hers) – University Hospital Wuerzburg

  Co-Author: Max Kurlbaum, PhD – University Hospital Würzburg

  Co-Author: Nicole Reisch, MD, PhD – Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München

  Co-Author: Alexandra Sophia Triebig, M.Sc. – LMU University Hospital

  Co-Author: Oliver Scherf-Clavel, PhD – LMU Munich

  Co-Author: Cornelia Fiessler, PhD – University Hospital Würzburg

  Co-Author: Martin Fassnacht, MD – University of Wuerzburg

  Oral Abstract Presenter: Matthias Kroiss (he/him/his) – UNIVERSITY OF WUERZBURG

  Senior Author/Primary Investigator: Matthias Kroiss (he/him/his) – UNIVERSITY OF WUERZBURG
• 3:30 PM - 4:15 PM CT

  Zilurgisertib in Patients With Fibrodysplasia Ossificans Progressiva: Interim Results From the PROGRESS Study
  

  Rapid and Poster Presenter: Robert Pignolo, MD, PhD – Mayo Clinic

  Co-Author: Caifeng Li, MD – Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health

  Co-Author: F. Javier Bachiller-Corral, MD – Hospital Universitario Ramón y Cajal

  Co-Author: Amanda McBride, MD, PhD – Incyte

  Co-Author: Sue Moran, MSN – Incyte

  Co-Author: Qian Li, PhD – Incyte

  Co-Author: Frederick Kaplan, MD – University of Pennsylvania Perelman School of Medicine

  Senior Author/Primary Investigator: Mona Almukaddam, MD – University OF PENNSYLVANIA